BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Analysts Say St. Jude Medical (STJ) May Face New Recall


1/17/2013 10:39:38 AM

Analysts said Wednesday that regulators may be moving toward a recall of St. Jude Medical Inc.'s Durata heart wires, a potentially "ominous" development for the company which has been plagued by recalls of its Riata wires. THE OPINION: St. Jude has recalled several heart device wires in the last few years because the insulation of some of the wires had failed. The Food and Drug Administration has been inspecting the facility where St. Jude makes its implantable heart defibrillators, which are devices implanted in the chest to correct dangerous heart rhythms. On Monday St. Jude Medical disclosed in a regulatory filing that the agency said its inspectors found inconsistencies in how the company manufactured and documented defibrillators. The FDA will not allow any new products to be made at the plant until problems with manufacturing and quality control are fixed. St. Jude disclosed the inspections in mid-October and said it expected a warning letter. The company has said that the insulation problems don't affect its newest heart wire, Durata, because it is coated with a different material. But the FDA is looking at Durata closely and analysts say a recall could be on the way. Citi Investment Research analyst Matthew Dodds said the warning letter is the "next step in a process that looks ominous for St. Jude." Dodds said he thinks the issue won't be cleared up soon, but a Durata recall is "likely." He has said in the past that he thinks Wall Street is overlooking the possibility of such a move.

Read at BusinessWeek

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES